EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention

Annette Gawron Roberts, Noelle Younge, Rachel Gottron Greenberg

Pediatric Drugs · 2024-05 · 26 (3) · 259-275

DOI: 10.1007/s40272-024-00626-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Drugs, online erschienen am 02.04.2024. Verfasst von Annette Gawron Roberts und 2 weiteren Autor:innen. Beteiligte Einrichtung: Duke University Hospital, Durham, NC, USA. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Milk, Human. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 181 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Necrotizing enterocolitis (NEC) is a life-threatening disease predominantly affecting premature and very low birth weight infants resulting in inflammation and necrosis of the small bowel and colon and potentially leading to sepsis, peritonitis, perforation, and death. Numerous research efforts have been made to better understand, treat, and prevent NEC. This review explores a variety of factors involved in the pathogenesis of NEC (prematurity, low birth weight, lack of human breast milk exposure, alterations to the microbiota, maternal and environmental factors, and intestinal ischemia) and reports treatment modalities surrounding NEC, including pain medications and common antibiotic combinations, the rationale for these combinations, and recent antibiotic stewardship approaches surrounding NEC treatment. This review also highlights the effect of early antibiotic exposure, infections, proton pump inhibitors (PPIs), and H2 receptor antagonists on the microbiota and how these risk factors can increase the chances of NEC. Finally, modern prevention strategies including the use of human breast milk and standardized feeding regimens are discussed, as well as promising new preventative and treatment options for NEC including probiotics and stem cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterocolitis, NecrotizingMilk, HumanHumansInfant, NewbornAnti-Bacterial AgentsProbioticsRisk FactorsInfant, Premature

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Duke University Hospital, Durham, NC, USA.
  • Duke University Hospital, Durham, NC, USA. rachel.greenberg@duke.edu.

Zitieren

APA

Roberts, A. G., Younge, N., & Greenberg, R. G. (2024). Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention. Pediatric Drugs, 26(3), 259-275. https://doi.org/10.1007/s40272-024-00626-w

Vancouver

Roberts AG, Younge N, Greenberg RG. Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention. Pediatric Drugs. 2024;26(3):259-275. doi:10.1007/s40272-024-00626-w

BibTeX
@article{Roberts2024,
  author = {Roberts, Annette Gawron and Younge, Noelle and Greenberg, Rachel Gottron},
  title = {Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention},
  journal = {Pediatric Drugs},
  year = {2024},
  volume = {26},
  number = {3},
  pages = {259--275},
  doi = {10.1007/s40272-024-00626-w}
}
Kostenlos starten →